| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medico Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹38.56 |
| 52 Week High | ₹92.87 |
| 52 Week Low | ₹35.00 |
| Beta | 0.10 |
| 11 Month Change | 0.052% |
| 3 Month Change | -20.92% |
| 1 Year Change | -42.95% |
| 33 Year Change | 382.00% |
| 5 Year Change | 818.10% |
| Change since IPO | 693.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540937 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.6% | -0.7% | 1.0% |
| 1Y | -43.0% | 51.1% | 43.7% |
Return vs Industry: 540937 underperformed the Indian Pharmaceuticals industry which returned 51.1% over the past year.
Return vs Market: 540937 underperformed the Indian Market which returned 43.7% over the past year.
Price Volatility
| 540937 volatility | |
|---|---|
| 540937 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 540937's share price has been volatile over the past 3 months.
Volatility Over Time: 540937's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 150 | Harshit Mehta | www.medicoremedies.com |
Medico Remedies Limited manufactures and sells pharmaceutical formulations in India. The company offers antibiotics and anti-infectives; beta-lactams- penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It primarily exports its products.
Medico Remedies Limited Fundamentals Summary
| 540937 fundamental statistics | |
|---|---|
| Market cap | ₹3.20b |
| Earnings (TTM) | ₹82.91m |
| Revenue (TTM) | ₹1.45b |
38.6x
P/E Ratio2.2x
P/S RatioIs 540937 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540937 income statement (TTM) | |
|---|---|
| Revenue | ₹1.45b |
| Cost of Revenue | ₹1.10b |
| Gross Profit | ₹350.14m |
| Other Expenses | ₹267.23m |
| Earnings | ₹82.91m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.00 |
| Gross Margin | 24.16% |
| Net Profit Margin | 5.72% |
| Debt/Equity Ratio | 12.9% |
How did 540937 perform over the long term?
See historical performance and comparison